论文部分内容阅读
辉瑞公司的新药 Zoloft(Sertraline)已得到美国FDA 的初步批准,该药用于治疗抑郁症.该药上市后,将成为 Eli Lilly 公司每年10亿美元收入的氟西汀(fluoxetine)的第一个竞争对手.
Pfizer’s new drug, Zoloft (Sertraline), which has been initially approved by the U.S. FDA for the treatment of depression, will be Eli Lilly’s first billion-dollar fluoxetine after it goes public Competitors.